The differences on the mRNA level were validated with immunofluorescence staining, which revealed an increased number of Il-6-positive cells in untreated RDEB forepaws and a decrease after losartan treatment (Fig7D). The gene discussed is IL6; the disease is recessive dystrophic epidermolysis bullosa.